Completed PHASE4 INTERVENTIONAL NCT00297739

Risperidone Augmentation for Treatment-Resistant Aggression in ADHD

Sponsor: Armenteros, Jorge L., M.D., P.A.

Interventions Risperidone

Updated 5 times since 2017 Last updated: Mar 15, 2006 Started: Jan 31, 2003 Completion: Apr 30, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Aggression, this trial is completed. The trial is conducted by Armenteros, Jorge L., M.D., P.A. and has accumulated 5 data snapshots since 2003. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jan 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Armenteros, Jorge L., M.D., P.A.
Janssen, LP

Data source: Armenteros, Jorge L., M.D., P.A.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Coral Gables, United States